Accelerating Medicines Partnership® SCHIZOPHRENIA
News and Updates
Keep up with the latest news about the Accelerating Medicines Partnership (AMP®) SCZ program.

Conference Presentations


Upcoming Conferences

Schizophrenia International Research Society (SIRS) Congress, March 29-April 2, 2024, Chicago, Illinois

Sunday, March 30, 2025

3:30-5 p.m. Regency Ballroom C

  • Expanding the Frontiers of CHR Research – Baseline Analyses From the Accelerating Medicines Partnership® – Schizophrenia Consortium
    Michael Sand (Chair), Scott Woods (Co-Chair), John Torous (Presenter), Jean Addington (Presenter), Phillip Wolff (Presenter), Kathryn Lewandowski (Presenter), Carlos Larrauri (Discussant)

    • Exploring Digital Phenotyping Data in AMP SCZ – John Torous
    • Clinical Characteristics of Youth at Risk for Developing Psychosis in AMP SCZ – Jean Addington
    • Utilizing Generative AI for Early Detection of Psychosis: Linguistic Feature Clustering and Risk Differentiation in CHR Populations – Phillip Wolff
    • Characterizing Cognition in Clinical High Risk – Eve Lewandowski
Tuesday, April 1, 2025

3-4:30 p.m. Crystal Ballroom BC

  • Emerging Advances in Transdiagnostic Phenotyping From Large-Scale Studies of Clinical High Risk for Psychosis
    Henry Cowan (Chair), Vijay Mittal (Co-Chair), Trevor Williams (Presenter), Henry Cowan (Presenter), Katrina Aberizk (Presenter), Jenna Reinen (Presenter), Carrie Bearden (Discussant)

      Transdiagnostic Hierarchical Symptom Models in a Clinical High Risk for Psychosis Sample – Trevor Williams
      Premorbid Adjustment Trajectories as a Developmental Signal to Differentiate Attenuated Negative Symptoms from Depression and Anxiety – Henry Cowan
      Relations of Perceived and Neuroendocrine Stress with Brain Morphometry on the Psychosis Spectrum – Katrina Aberizk
      Using Large Language Models and Lived Experience Patient Narratives to Characterize Linguistic Features of Clinical High Risk – Jenna Reinen

Past Conferences

Schizophrenia International Research Society (SIRS) Congress, April 3-7, 2024, Florence Italy

Thursday, April 4, 2024

10 a.m. – 12 p.m. Symposia, Auditorium

  • Predicting Outcome in UHR: A Perspective From Data Analysis and Study Coordination
    René Kahn (Chair), Martha Shenton (Co-Chair), Cheryl Corcoran (Presenter), Sylvain Bouix (Presenter), Ofer Pasternak (Presenter), Tina Kapur (Presenter), René Kahn (Discussant)

12 p.m. – 2 p.m. Poster Presentation, Cavaniglia Pavilion

  • T136. The PSYCHS: Positive Symptoms and Diagnostic Criteria for the CAARMS Harmonized With the SIPS: A Research Instrument for Therapeutics Development in Clinical High Risk for Psychosis Psychometric Evaluations of the PSYCHS Interview
    Catalina Mourgues-Codern, Jean Addington, Martha E. Shenton, Barnaby Nelson, Alison Yung, Scott Woods
  • T200. Analysing Resting-State fMRI Connectivity Patterns in Individuals at Clinical High-Risk for Psychosis: Preliminary Insights
    Chloe Clifford, Elizabeth Farrow, Matthew R. Broome, Charles Large, Rachel Upthegrove, Jack Rogers
Saturday, April 6, 2024

5:30 p.m. – 7:30 p.m. Modulo 1 – Affari
Oral Session: Subclinical Populations, High Clinical Risk and Early Onset Psychosis

  • Comparative Analysis of CHR-P and UHR Profiles Derived From PSYCHS Interview: Insights from SIPS and CAARMS Assessments in Early Psychosis Intervention
    Catalina Mourgues-Codern, Paolo Fusar-poli, Jai Shah, Scott Woods

Last Reviewed on March 5, 2025